1Albers, R, Antoine, J, Bourdet-Sicard, R, et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452–481.
2Christou, NV, Tellado-Rodriguez, J, Chartrand, L, Giannas, B, Kapadia, B, Meakins, J, Rode, H & Gordon, J (1989) Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response. Ann Surg 210, 69–77.
3Wayne, SJ, Rhyne, RL, Garry, PJ & Goodwin, JS (1990) Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 45, M45–M48.
4Lesourd, BM, Wang, A & Moulias, R (1985) Serial delayed cutaneous hypersensitivity skin testing with multiple recall antigens in healthy volunteers: booster effect study. Ann Allergy 55, 729–735.
5Grabenstein, GD (2002) Immunofacts: Vaccines and Immunologic Drugs. St. Louis: Wolters Kluwer Company.
6England, R, Nugent, J, Grathwohl, K, Hagan, L & Quinn, J (2003) High-dose inhaled fluticasone and delayed hypersensitivity skin testing. Chest 123, 1014–1017.
7Martinez-Marcos, FJ, Lopez-Cortes, LF, Pachon, J, Alarcon, A, Cordero, E & Viciana, P (1998) Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection. Clin Infect Dis 26, 1330–1334.
8Vine, M, Stein, L & Weigle, K (2000) Gender differences in response to the multitest CMI skin test in the general population. Ann Allergy Asthma Immunol 84, 445–450.
9Cauthen, GM, Snider, DE Jr & Onorato, IM (1994) Boosting of tuberculin sensitivity among Southeast Asian refugees. Am J Respir Crit Care Med 149, 1597–1600.